Respiratory syncytial virus is estimated to affect approximately 5 million cases this year in the United States and 2.5 million RSV cases in the EU4 countries and the United Kingdom. As per Delveinsight analysis on the latest published “Respiratory Syncytial Virus Epidemiology Report,” the US comprised ~70%, ~27%, and ~3% of the total number of mild, moderate, and severe cases of respiratory syncytial virus in children, respectively, in 2022. Whereas ~17%, ~64%, and ~19% of the mild, moderate, and severe cases of respiratory syncytial virus in adults, respectively, in 2022.
Despite such a high number of incident cases, there is still a high unmet need for effective...
